Targeting the ASB3-CPT1A axis-a new player in combating metabolic dysfunction-associated steatotic liver disease: Editorial on "Hepatocytic ankyrin repeat and SOCS box protein 3 deficiency alleviates metabolic dysfunction-associated steatotic liver disease by decreasing ubiquitin-mediated carnitine palmitoyltransferase 1A"

靶向 ASB3-CPT1A 轴——对抗代谢功能障碍相关脂肪肝疾病的新策略：关于“肝细胞锚蛋白重复序列和 SOCS 盒蛋白 3 缺乏通过降低泛素介导的肉碱棕榈酰转移酶 1A 来缓解代谢功能障碍相关脂肪肝疾病”的社论